# REO13 Melanoma With of Without GM-CSF

> **NCT03282188** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University of Leeds**

## Conditions studied

- Melanoma
- Cancer of Skin

## Interventions

- **BIOLOGICAL:** Reolysin
- **DRUG:** GM-CSF

## Key facts

- **NCT ID:** NCT03282188
- **Lead sponsor:** University of Leeds
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-10
- **Primary completion:** 2018-07
- **Final completion:** 2018-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Withdrawn by Sponsor
- **Last updated:** 2018-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03282188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03282188, "REO13 Melanoma With of Without GM-CSF". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03282188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*